NCI-H2122 In Vivo Tumorigenesis Assay

This assay is to provide NCI-H2122-based In Vivo Tumorigenesis Assay to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.

NCI-H2122

Human

NCI-H2122 [H2122] cells are lymphoblasts isolated in 1989 from a pleural effusion metastasis derived from a 46-year-old female smoker. Use these cells in lung cancer research.

H2122

Non Small Cell Lung Cancer

Oncology

In Vivo Tumorigenesis Assay

Tumorigenicity is defined the property of a cell to form tumors when inoculated into an immunosuppressed animal model. Generally, test cells and tumor cells as positive control are administered subcutaneously into immunosuppressed nude mice. The number of animals developing tumors are compared with a positive control reference cell line.

Oncology In Vivo Assays